Skip to main content
Back
Watch Compare

ANAPTYSBIO, INC

Data quality: 100%
ANABV
Nasdaq Manufacturing Chemicals
$43.55
▲ $0.11 (0.25%)
Mkt Cap: 1.25 B
Price
$43.55
Mkt Cap
1.25 B
Day Range
$41.99 — $47.00
52-Week Range
$41.99 — $47.00
Volume
2,999
Open $42.00
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Revenue grew 38.82% annually over 5 years — strong growth
Generating 19.61 M in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 118.19%
Capital efficient — spends only 0.04% of revenue on capex

Growth

Revenue Growth (5Y)
38.82%
Above sector avg (9.35%)
Revenue (1Y)157.01%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
N/A
ROIC12.31%
Net Margin-5.64%
Op. Margin20.42%

Safety

Debt / Equity
N/A
Current Ratio8.68
Interest CoverageN/A

Valuation

PE (TTM)
-94.65
Below sector avg (-1.98)
P/B RatioN/A
EV/EBITDA23.58
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (44 peers)
Metric Stock Sector Median
P/E -94.7 -2.0
P/B — 5.1
ROE % — -51.0
Net Margin % -5.6 -150.2
Rev Growth 5Y % 38.8 9.3
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) 157.01% Revenue Growth (3Y) 269.78%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 38.82% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 234.60 M Net Income (TTM) -13.23 M
ROE N/A ROA -3.84%
Gross Margin N/A Operating Margin 20.42%
Net Margin -5.64% Free Cash Flow (TTM) 19.61 M
ROIC 12.31% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 8.68
Interest Coverage N/A Asset Turnover 0.68
Working Capital 292.55 M Tangible Book Value -29.42 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -94.65 Forward P/E N/A
P/B Ratio N/A P/S Ratio 5.34
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 23.58 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 1.57%
Market Cap 1.25 B Enterprise Value 1.14 B
Per Share
EPS (Diluted TTM) -0.46 Revenue / Share 8.16
FCF / Share 0.68 OCF / Share 0.68
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0.04% FCF Conversion -148.20%
SBC-Adj. FCF -16.15 M Growth Momentum 118.19

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 234.60 M 91.28 M 17.16 M 10.29 M 63.18 M
Net Income -13.23 M -145.23 M -163.62 M -128.72 M -57.80 M
EPS (Diluted) -0.46 -5.12 -6.08 -4.57 -2.11
Gross Profit — — — — —
Operating Income 47.90 M -114.95 M -164.41 M -115.15 M -56.81 M
EBITDA — — — — —
R&D Expenses — — — 88.80 M 98.50 M
SG&A Expenses — — — — —
D&A 559,000.0 606,000.0 652,000.0 675,000.0 619,000.0
Interest Expense — — — — 0.0
Income Tax 164,000.0 3,000.0 -4,000.0 24,000.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 364.40 M 483.83 M 452.39 M 610.38 M 643.07 M
Total Liabilities — — — — —
Shareholders' Equity 37.21 M 70.87 M 88.10 M 262.10 M 356.43 M
Total Debt — — — — —
Cash & Equivalents 238.20 M 123.08 M 35.97 M 71.31 M 495.73 M
Current Assets 350.25 M 431.88 M 406.84 M 447.21 M 553.88 M
Current Liabilities 38.63 M 45.43 M 37.44 M 26.05 M 16.10 M